A novel human recombinant antibody fragment capable of neutralizing Mexican scorpion toxins. 2013

Lidia Riaño-Umbarila, and Timoteo Olamendi-Portugal, and Citlalli Morelos-Juárez, and Georgina B Gurrola, and Lourival D Possani, and Baltazar Becerril
Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, UNAM, Apartado Postal 510-3, Cuernavaca 62250, Morelos, Mexico.

Using phage display and directed evolution, our group has progressed in the construction of a second family of human single chain variable fragments (scFv) which bind to scorpion toxins dangerous to mammals. It was observed that scFv C1 only bound initially to toxin Cn2, which constitutes 6.8% of whole venom from the scorpion Centruroides noxius Hoffman. Only a few amino acid changes were necessary to extend its recognition to other similar toxins and without affecting the recognition for its primary antigen (Cn2 toxin). One variant of scFv C1 (scFv 202F) was selected after two cycles of directed evolution against Cll1 toxin, the second major toxic component from the venom of the Mexican scorpion Centruroides limpidus limpidus Karsh (0.5% of the whole venom). scFv 202F is also capable of recognizing Cn2 toxin. Despite not having the highest affinity for toxins Cll1 (KD = 25.1 × 10(-9) M) or Cn2 (KD = 8.1 × 10(-9) M), this antibody fragment neutralized one LD50 of each one of these toxins. Additionally, scFv 202F moderately recognized Cll2 toxin which constitutes 1.5% of the venom from C. limpidus. Based on our previous experience, we consider that these results are promising; consequently, we continue working on generating new optimized variants from scFv C1 that could be part of a recombinant scorpion anti-venom from human origin, that might reach the market in the near future.

UI MeSH Term Description Entries
D007128 Immunoglobulin Fragments Partial immunoglobulin molecules resulting from selective cleavage by proteolytic enzymes or generated through PROTEIN ENGINEERING techniques. Antibody Fragment,Antibody Fragments,Ig Fragment,Ig Fragments,Immunoglobulin Fragment,Fragment, Antibody,Fragment, Ig,Fragment, Immunoglobulin,Fragments, Antibody,Fragments, Ig,Fragments, Immunoglobulin
D008800 Mexico A country in NORTH AMERICA, bordering the Caribbean Sea and the Gulf of Mexico, between BELIZE and the UNITED STATES, and bordering the North Pacific Ocean, between Guatemala and the UNITED STATES.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000997 Antivenins Antisera used to counteract poisoning by animal VENOMS, especially SNAKE VENOMS. Anti-Venin,Anti-Venom,Antivenin,Antivenom,Anti-Venins,Anti-Venoms,Antivenoms,Anti Venin,Anti Venins,Anti Venom,Anti Venoms
D012604 Scorpion Venoms Venoms from animals of the order Scorpionida of the class Arachnida. They contain neuro- and hemotoxins, enzymes, and various other factors that may release acetylcholine and catecholamines from nerve endings. Of the several protein toxins that have been characterized, most are immunogenic. Scorpion Toxin,Scorpion Toxins,Scorpion Venom Peptide,Tityus serrulatus Venom,Scorpion Venom,alpha-Scorpion Toxin,beta-Scorpion Toxin,gamma-Scorpion Toxin,Peptide, Scorpion Venom,Toxin, Scorpion,Toxin, alpha-Scorpion,Toxin, beta-Scorpion,Venom Peptide, Scorpion,Venom, Scorpion,Venom, Tityus serrulatus,alpha Scorpion Toxin,beta Scorpion Toxin,gamma Scorpion Toxin
D016415 Sequence Alignment The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms. Sequence Homology Determination,Determination, Sequence Homology,Alignment, Sequence,Alignments, Sequence,Determinations, Sequence Homology,Sequence Alignments,Sequence Homology Determinations

Related Publications

Lidia Riaño-Umbarila, and Timoteo Olamendi-Portugal, and Citlalli Morelos-Juárez, and Georgina B Gurrola, and Lourival D Possani, and Baltazar Becerril
January 2014, Journal of immunotoxicology,
Lidia Riaño-Umbarila, and Timoteo Olamendi-Portugal, and Citlalli Morelos-Juárez, and Georgina B Gurrola, and Lourival D Possani, and Baltazar Becerril
April 2000, Journal of medical virology,
Lidia Riaño-Umbarila, and Timoteo Olamendi-Portugal, and Citlalli Morelos-Juárez, and Georgina B Gurrola, and Lourival D Possani, and Baltazar Becerril
May 2024, Toxicon : official journal of the International Society on Toxinology,
Lidia Riaño-Umbarila, and Timoteo Olamendi-Portugal, and Citlalli Morelos-Juárez, and Georgina B Gurrola, and Lourival D Possani, and Baltazar Becerril
September 2022, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Lidia Riaño-Umbarila, and Timoteo Olamendi-Portugal, and Citlalli Morelos-Juárez, and Georgina B Gurrola, and Lourival D Possani, and Baltazar Becerril
January 2007, Cellular and molecular life sciences : CMLS,
Lidia Riaño-Umbarila, and Timoteo Olamendi-Portugal, and Citlalli Morelos-Juárez, and Georgina B Gurrola, and Lourival D Possani, and Baltazar Becerril
October 2003, Virology,
Lidia Riaño-Umbarila, and Timoteo Olamendi-Portugal, and Citlalli Morelos-Juárez, and Georgina B Gurrola, and Lourival D Possani, and Baltazar Becerril
January 2002, Toxicon : official journal of the International Society on Toxinology,
Lidia Riaño-Umbarila, and Timoteo Olamendi-Portugal, and Citlalli Morelos-Juárez, and Georgina B Gurrola, and Lourival D Possani, and Baltazar Becerril
May 2015, Biochemical and biophysical research communications,
Lidia Riaño-Umbarila, and Timoteo Olamendi-Portugal, and Citlalli Morelos-Juárez, and Georgina B Gurrola, and Lourival D Possani, and Baltazar Becerril
November 2016, Toxicon : official journal of the International Society on Toxinology,
Lidia Riaño-Umbarila, and Timoteo Olamendi-Portugal, and Citlalli Morelos-Juárez, and Georgina B Gurrola, and Lourival D Possani, and Baltazar Becerril
March 2017, Methods (San Diego, Calif.),
Copied contents to your clipboard!